Dose-Dependent Influence of Vitamin D₃ on Blood Cell Indices and Clotting Function in Rats with Phenylhydrazine-Induced Haemolytic Anaemia
Abstract
Background. Coagulation disturbances often coexist with anaemia but are rarely studied together. Vitamin D receptors on megakaryocytes and erythroid precursors suggest this hormone may influence both erythropoiesis and haemostasis simultaneously. Aim. To determine whether oral vitamin D₃ restores blood counts, iron status and clotting times in a rat model of phenylhydrazine-induced haemolytic anaemia, and how these outcomes relate to circulating 25-hydroxyvitamin D. Methods. Forty male Wistar rats were randomised into five groups (n = 8): untreated control; anaemia-only (phenylhydrazine 40 mg/kg i.p. on two days); two PHZ groups given oral vitamin D₃ (500 or 1000 IU/kg/day) for four weeks; and a PHZ group given weekly intramuscular iron dextran (10 mg/kg). Groups were compared by one-way ANOVA with Tukey's HSD; associations with 25(OH)D₃ were assessed by Pearson's correlation. Results. Phenylhydrazine reduced haemoglobin, RBC count, haematocrit, serum iron and ferritin, and prolonged PT and aPTT (all p < 0.01). Both vitamin D₃ doses improved Hb, RBC, MCV and platelets dose-dependently; the higher dose shortened PT and aPTT and raised fibrinogen. 25(OH)D₃ correlated positively with haemoglobin (r = +0.71, p < 0.001) and negatively with PT (r = −0.65, p < 0.001). Conclusion. Oral vitamin D₃ produced dose-dependent improvement in both the blood picture and clotting profile of anaemic rats, consistent with VDR-mediated effects on erythroid maturation and vitamin K-dependent clotting factors, and supports vitamin D₃ as a plausible adjunct in anaemia management.
